Direct delivery of Ngb protein [21] or Ngb gene therapy [19,21,23,24] in rodent models of retinal hypoxia, glaucoma, and cerebral ischaemia have also confirmed that the neuroprotective effects of Ngb can be reproduced by exogenous delivery. Here, NGB is linked to glaucoma.